Site TN-204 — Cumberland Arthritis Associates
Nashville, TN · Southeast · PI Dr. Peter Vance · Coordinator Alicia Monroe
On HoldHigh100
Activation Readiness
IRB / Ethics approvalExpired
Regulatory documents6/10 complete
Investigator trainingIn Progress
Staff trainingNot Started
ContractPending
BudgetPending
Planned activation2026-05-11 (102 days overdue)
Enrollment
0of 20 patients (0%)
Enrollment rate0 patients / month
StatusNot started
Operations
Data entryNot Started
Open data queries0
Protocol deviations0
Outstanding tasks9
Last site activity27 days ago
Last monitoring visitNot yet visited
Agent Assessment
HighRisk score
100/100
Why am I seeing this?
TN-204 was classified as High Risk because irb approval expired, 4 required regulatory documents missing, planned activation date has passed.
Primary risk factors
- IRB approval expired+32 · RegulatoryIRB record is "Expired" — the site cannot enroll patients in this state.Source: Regulatory Document Repository
- 4 required regulatory documents missing+30 · Regulatory6/10 essential documents are on file.Source: Regulatory Document Repository
- Planned activation date has passed+28 · TimelinePlanned activation 2026-05-11; site is not yet activated.Source: CTMS site activation record
- Site staff training not started+14 · TrainingCoordinator/staff protocol training is not complete.Source: Site Training Records (LMS)
- Clinical trial agreement pending+12 · RegulatoryExecuted contract is required prior to activation.Source: CTMS contract record
- No site activity for 27 days+12 · EngagementSite has not logged activity in CTMS recently.Source: CTMS activity log
- Investigator training in progress+10 · TrainingProtocol training for the principal investigator is not complete.Source: Site Training Records (LMS)
- Budget pending+8 · RegulatorySite budget approval is outstanding.Source: CTMS budget record
Recommended action
Contact Site Coordinator Alicia Monroe regarding the outstanding IRB approval and 4 missing regulatory documents.
Agent actions for this site
No actions prepared yet for TN-204 in trial CT-2026-301.